“My expectation talking to the group of scientists we put together, over 20 of them plus others in the field, is that sometime maybe in the beginning of the school year, at the end of August, beginning of September, October, they’ll get a final approval,” President Biden said.
The COVID-19 vaccines currently being administered under FDA-granted emergency use authorizations are produced by Pfizer, Moderna and Johnson & Johnson. In May, Pfizer applied for its vaccine’s full approval. Moderna did the same in June.
During the town hall, President Biden also said he expected emergency use authorization for COVID-19 vaccines to be used in children under age 12 “soon, I believe.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
